860695 | Glucosyl(β) Sphingosine-d7
D-glucosyl-β-1,1’-D-erythro-sphingosine-d7
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Glucosyl(β) Sphingosine-d7
D-glucosyl-β-1,1’-D-erythro-sphingosine-d7
C24H40D7NO7
C 61.50%, H 11.61%, N 2.99%, O 23.90%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by BiozIrún P, Cebolla JJ, López de Frutos L, De Castro-Orós I, Roca-Espiau M, Giraldo P. LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population. Clin Chem Lab Med. 2020 Apr 28;58(5):798-809. doi: 10.1515/cclm-2019-0949. PMID: 32126008.
PubMed ID: 32126008Gündner AL, Duran-Pacheco G, Zimmermann S, Ruf I, Moors T, Baumann K, Jagasia R, van de Berg WDJ, Kremer T. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels. Neurobiol Dis. 2019 Jan;121:205-213. doi: 10.1016/j.nbd.2018.09.015. Epub 2018 Sep 17.
PubMed ID: 30236861- Certificate of Analysis (Lot No. 860695P-1MG-A-010 and 6616PGA010)
- Certificate of Analysis (Lot No. 860695P-1MG-C-010 and 6616PGC010)
- Certificate of Analysis (Lot No. 860695P-1MG-D-010 and 6616PGD010)
